Charles Carroll Financial Partners, LLC Johnson & Johnson Transaction History

Charles Carroll Financial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $15,886 - $17,796	102 Added 7.54%	1,455 $226,000
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $61,740 - $66,444	-400 Reduced 22.82%	1,353 $223,000
Q1 2023 May 08, 2023	SELL	$151.05 - $180.26 $279,442 - $333,481	-1,850 Reduced 51.35%	1,753 $271,000
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $16,019 - $17,979	100 Added 2.85%	3,603 $636,000
Q2 2022 Jul 27, 2022	BUY	$168.19 - $186.01 $589,169 - $651,593	3,503 New	3,503 $622,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Charles Carroll Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Charles Carroll Financial Partners, LLC with notifications on news.